LNSR Earnings Date: Nov 12, 2026 (Estimated) — LENSAR Inc
NASDAQ · Healthcare · Medical Devices
Updated
When is LNSR's next earnings date?
LENSAR Inc (LNSR) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.10 on revenue of $14.3M.
How did LNSR do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), LENSAR Inc posted EPS of $0.10 versus the -$0.17 estimate, a beat of 137.0%. Revenue was $16.5M against a $14.7M estimate. The stock's 1-day post-earnings move was +31.5%.
How much does LNSR stock move after earnings?
LNSR beat EPS estimates in 3 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 12.1% (up or down) in the day after earnings.
About LENSAR Inc
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -0.17 | 0.10 | +137.04% | $16.5M | ✅ Beat | +31.48% | +38.63% | +20.83% |
| 2026-05-08 | Q1 2026 | 0.49 | 0.00 | -100.00% | $13.4M | ❌ Miss | +7.84% | +11.47% | +7.07% |
| 2026-03-31 | Q4 2025 | -0.10 | -0.12 | -20.00% | $16.0M | ❌ Miss | +1.53% | -4.09% | -8.18% |
| 2025-11-06 | Q3 2025 | -0.08 | -0.31 | -287.50% | $14.3M | ❌ Miss | -8.63% | -16.85% | -10.54% |
| 2025-02-27 | Q4 2024 | -0.18 | -1.61 | — | $16.7M | ❌ Miss | +14.78% | +61.99% | +49.31% |
| 2024-11-07 | Q3 2024 | -0.29 | -0.13 | +55.17% | $13.5M | ✅ Beat | +17.24% | +26.11% | +31.40% |
| 2024-05-09 | Q1 2024 | -0.28 | -0.19 | +32.14% | $10.6M | ✅ Beat | +12.68% | +22.42% | +35.99% |
| 2024-03-04 | Q4 2023 | -0.22 | -0.35 | -59.09% | $12.1M | ❌ Miss | +2.77% | -12.98% | -26.81% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $14.7M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Product | 88.6% | $13.0M | +19.5% | $23.1M | $10.9M | $10.9M | $11.4M |
| Service | 11.4% | $1.7M | +21.8% | $2.5M | $1.4M | $1.4M | $1.4M |
By region
Q2 FY26 · $14.7M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 70.6% | $10.4M | +34.2% | $16.8M | $6.7M | $7.8M | $8.7M |
| Europe | 15.7% | $2.3M | -4.3% | $5.2M | $2.2M | $2.4M | $2.3M |
| Asia | 13.3% | $2.0M | — | — | — | — | — |
| Other Geographical Region | 0.4% | $62K | -18.4% | $446K | $67K | $76K | $41K |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.